Literature DB >> 9134875

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

R S Vasan1, M G Larson, E J Benjamin, J C Evans, D Levy.   

Abstract

BACKGROUND: Left ventricular dilatation is a well-recognized precursor of ventricular dysfunction and congestive heart failure after myocardial infarction. The effect of left ventricular dilatation on the risk of heart failure in people initially free of myocardial infarction is not known.
METHODS: We examined the relation of the left ventricular end-diastolic and end-systolic internal dimensions, as measured by M-mode echocardiography, to the risk of congestive heart failure in 4744 subjects (2083 men and 2661 women) who had not sustained a myocardial infarction and who were free of congestive heart failure. We used sex-stratified proportional-hazards regression to assess the association between base-line left ventricular internal dimensions and the subsequent risk of congestive heart failure, after adjusting for age, blood pressure, hypertension treatment, body-mass index, diabetes, valve disease, and interim myocardial infarction.
RESULTS: Over an 11-year follow-up period, congestive heart failure developed in 74 subjects (38 men and 36 women). The risk-factor-adjusted hazard ratio for congestive heart failure was 1.47 (95 percent confidence interval, 1.25 to 1.73) for an increment of 1 SD in the left ventricular end-diastolic dimension, indexed for height. We obtained similar results using the left ventricular end-systolic dimension (hazard ratio, 1.43; 95 percent confidence interval, 1.24 to 1.65).
CONCLUSIONS: An increase in left ventricular internal dimension is a risk factor for congestive heart failure in men and women who have not had a myocardial infarction. Knowledge of the left ventricular dimension improves predictions of the risk of congestive heart failure made on the basis of traditional risk factors, perhaps by aiding in the identification of subjects with subclinical left ventricular dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9134875     DOI: 10.1056/NEJM199705083361903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  96 in total

Review 1.  Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Authors:  R S McKelvie; C R Benedict; S Yusuf
Journal:  BMJ       Date:  1999-05-22

2.  Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis).

Authors:  Raymond T Yan; David Bluemke; Antoinette Gomes; Gregory Burke; Steve Shea; Kiang Liu; Hossein Bahrami; Shantanu Sinha; Colin Wu; Veronica Fernandes; Robyn McClelland; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2011-04-26       Impact factor: 24.094

3.  Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Authors:  Adeel A Butt; Chung-Chou Chang; Lewis Kuller; Matthew Bidwell Goetz; David Leaf; David Rimland; Cynthia L Gibert; Krisann K Oursler; Maria C Rodriguez-Barradas; Joseph Lim; Lewis E Kazis; Stephen Gottlieb; Amy C Justice; Matthew S Freiberg
Journal:  Arch Intern Med       Date:  2011-04-25

Review 4.  The role of brain natriuretic peptide in population screening.

Authors:  Liselotte N Dyrbye; Margaret M Redfield
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

Review 5.  Screening for left ventricular dysfunction: a step too far?

Authors:  T A McDonagh
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

6.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

7.  The epidemiology of congestive heart failure: the Framingham Heart Study perspective.

Authors:  Syed S Mahmood; Thomas J Wang
Journal:  Glob Heart       Date:  2013-03-01

8.  Cardiac remodeling as therapeutic target: treating heart failure with Cardiac Support Devices.

Authors:  Douglas L Mann
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

9.  Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

Authors:  Showkat A Haji; Rifat Eralp Ulusoy; Dharmendrakumar A Patel; Sathanur R Srinivasan; Wei Chen; Patrice Delafontaine; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

10.  Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.